- Home
- Carfilive 60 mg Injection 1's
Carfilive 60 mg Injection 1's Substitute
Carfilive 60 mg Injection 1's Substitute
Medicine Composition:
CARFILZOMIB-60MGAll Substitutes & Brand Comparisons
RX
Carfilnat 60Mg Inj
Natco Pharma Ltd
₹9365.5
(₹7679.7 per unit)
48% CHEAPERRX
Out of StockCarfican 60 mg Injection 1's
Lucien Life Sciences
₹9281
(₹9281.0 per unit)
38% CHEAPERRX
Carfizome 60Mg Inj
Intas Pharmaceuticals Ltd
₹11332
(₹9292.2 per unit)
38% CHEAPERRX
Out of StockMylocar 60 mg Injection 1's
BDR Pharmaceuticals Internationals Pvt Ltd
₹11700
(₹9594.0 per unit)
36% CHEAPERRX
Carzomib Injection 1's
Hetero Healthcare Pvt Ltd
₹13650
(₹11193.0 per unit)
25% CHEAPERRX
Adcarfil-60 Injection 1's
Admac Lifesciences(Oncology)
₹11444.5
(₹11444.5 per unit)
23% CHEAPERRX
Out of StockCarfimib 60 mg Injection 1's
Adley Formulations
₹12900
(₹12900.0 per unit)
14% CHEAPERRX
Kyfil 60 mg Injection 1's
Msn Laboratories Pvt Ltd
₹13500
(₹13500.0 per unit)
10% CHEAPERRX
Medcarmib 60 mg Injection 1's
Medion Biotech Pvt Ltd
₹15000
(₹15000.0 per unit)
RX
Carflieva 60 mg Injection 1's
Allieva Pharma Pvt Ltd
₹38156
(₹38156.0 per unit)
154% COSTLIERRX
Kyprolis 60 mg Injection 1's
Dr Reddy's Laboratories Ltd
₹44367
(₹39043.0 per unit)
160% COSTLIER
When Should You Consider Switching from Carfilive 60 mg Injection 1's?
Patients may explore substitutes in the following scenarios:
- High monthly cost of Carfilive 60 mg Injection 1's
- Non-availability in local pharmacies
- Generic recommendation by a doctor
- Side effects or better tolerability with alternatives
What to Know Before Switching
Before you switch from Carfilive 60 mg Injection 1's to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - CARFILZOMIB-60MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Uses
Carfilive 60 mg Injection 1's is used in the treatment of Multiple Myeloma. The detailed uses of Carfilive 60 mg Injection 1's are as follows:
- Relapsed or refractory multiple myeloma: Carfilive 60 mg Injection 1's is used for the treatment of multiple myeloma in adult patients whose cancer has relapsed or is refractory to one or more lines of therapy. It is specifically indicated when the disease becomes resistant to previous treatments, helping to slow disease progression and extend survival. By targeting cancer cells that have adapted to earlier therapies, Carfilive 60 mg Injection 1's provides a critical second-line or later treatment option.
- Combination therapy support: Carfilive 60 mg Injection 1's is used in combination with other agents such as dexamethasone or lenalidomide to enhance overall treatment efficacy in patients with relapsed or refractory multiple myeloma. These combinations have shown improved response rates and longer progression-free survival compared to monotherapy. The synergy between Carfilive 60 mg Injection 1's and these medications helps increase cancer cell death while maintaining manageable toxicity profiles.
- Proteasome inhibition in cancer therapy: Carfilive 60 mg Injection 1's is used as a selective proteasome inhibitor that blocks the activity of proteasomes, which are cellular structures responsible for breaking down unneeded or damaged proteins. In cancer cells, this inhibition disrupts protein homeostasis and causes toxic proteins to accumulate, leading to cellular stress and programmed cell death (apoptosis). By targeting the increased protein turnover demands of myeloma cells, Carfilive 60 mg Injection 1's effectively eliminates cancer cells while leaving most normal cells relatively unaffected.
Medicinal Benefits
Carfilzomib, a proteasome inhibitor, is present in Carfilive 60 mg Injection 1's. It suppresses proteasomes, preventing protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.
FAQs
The substitutes of Carfilive 60 mg Injection 1's contain the same active salt(s) - CARFILZOMIB-60MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Carfilive 60 mg Injection 1's is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Carfilive 60 mg Injection 1's are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Carfilive 60 mg Injection 1's meet the same safety and efficacy standards as Carfilive 60 mg Injection 1's, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Carfilive 60 mg Injection 1's may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Carfilive 60 mg Injection 1's if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Carfilive 60 mg Injection 1's for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Carfilive 60 mg Injection 1's is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Carfilive 60 mg Injection 1's to its substitute. Always consult your doctor before switching.
Carfilive 60 mg Injection 1's is used to treat Multiple Myeloma.
Carfilive 60 mg Injection 1's contains Carfilzomib, which inhibits proteasomes and thereby prevents protein breakdown in MM (multiple myeloma) cells. When the proteasome action within the MM cell is disturbed, a protein accumulation occurs, destroying the cancerous cells.
No, it is unsafe to father a child while taking Carfilive 60 mg Injection 1's. It is recommended for sexually active men to use condoms while on treatment and for at least several months after their last dose of Carfilive 60 mg Injection 1's.
Based on the medical condition, Carfilive 60 mg Injection 1's may be given alone or together with other medicines used to treat multiple myeloma.
Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.
Carfilive 60 mg Injection 1's can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.
Carfilive 60 mg Injection 1's treats multiple myeloma that has returned or no longer responds to treatment. It's often used with other medications. If you have questions or concerns, talk to your doctor. They will help you understand if Carfilive 60 mg Injection 1's is right for you.
Carfilive 60 mg Injection 1's is to be administered by intravenous infusion in a hospital setting under the supervision of a physician qualified to administer cancer chemotherapeutic agents.
Carfilive 60 mg Injection 1's is given on two consecutive days each week for three weeks followed by a 12-day rest period or it may be given once a week for 3 weeks followed by a 13-day rest period. However, the pattern and duration of treatment may vary. Please consult the doctor if you have any concerns.
You may experience nausea and extreme tiredness from Carfilive 60 mg Injection 1's. To cope with nausea, try eating small meals, avoiding strong smells, and staying hydrated. For tiredness, prioritize rest, break tasks into smaller chunks, and take regular breaks. Practice relaxation techniques like deep breathing, meditation, or yoga, and stay hydrated and energized with nutritious food. However, if these are bothering you consult your doctor immediately.
Carfilive 60 mg Injection 1's can lower your blood cell and platelet counts, increasing the risk of infections, anemia, and bleeding. To keep an eye on this, your doctor will likely order regular blood tests before and during treatment. Consult your doctor if you suspect any symptoms of low immunity like delayed healing or frequent infections.
If you experience any of the following, seek a doctor's advice right away: fever, infection signs, unusual bleeding, shortness of breath, chest pain, severe nausea, weakness, confusion, or severe headache. Also, consult your doctor if you have concerns or questions about your treatment, notice any health changes or side effects, miss a dose, or need to change your treatment schedule.
Carfilive 60 mg Injection 1's should not be taken during pregnancy as it might cause fetal harm. Inform your doctor immediately if you are pregnant or think you may be pregnant while on therapy.
Do not breastfeed while you are receiving Carfilive 60 mg Injection 1's and for two weeks after your final dose as it may pass into the breastmilk. Consult your doctor if you have any concerns regarding it.
